BIO-key International
BKYI
3 hedge funds and large institutions have $211K invested in BIO-key International in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
50% more funds holding
Funds holding: 2 → 3 (+1)
0% more ownership
Funds ownership: 0% → 0% (+0%)
12% less capital invested
Capital invested by funds: $240K → $211K (-$29K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$71.9K |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$47K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$2.77K |
BKYI Hedge Fund Activity: Q3 2018 in Review
3 of the 4,389 institutional investors tracked by Wall St. Rank reported a position in BIO-key International (BKYI) for Q3 2018, worth a combined $211K — down 12% from $240K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new BKYI positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $71.9K. The largest seller was UBS Group, exiting entirely with an estimated $2.77K sold.
- 3 institutional investors held BIO-key International (BKYI) as of Q3 2018, up from 2 in Q2 2018.
- Funds reported $211K of BIO-key International stock for Q3 2018, down 12% quarter-over-quarter.
- 2 funds opened new BIO-key International positions in Q3 2018 and 1 closed out, a net change of +1 holder.
- The largest BIO-key International buyer in Q3 2018 was Vanguard Group, an estimated $71.9K added.
- The largest BIO-key International seller in Q3 2018 was UBS Group, an estimated $2.77K sold.
Based on aggregated 13F filings for Q3 2018.